A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal

ConclusionsA portal-based osteoporosis DA was acceptable and improved several measures of decision quality. Given its effect on improving the quality of patients ’ decisions, future studies should examine whether it improves physician guideline adherence or medication adherence uptake among treated patients.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research